Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Unprotected Left Main Coronary Artery

Zhenzhen Wang1, Biming Zhan1, Huihui Bao1

  • 1Department of Cardiovascular Medicine, Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.

Insights

Percutaneous coronary intervention (PCI) with stents shows reduced stroke risk compared to coronary artery bypass graft surgery (CABG) for unprotected left main stenosis. CABG leads to fewer long-term complications, while PCI is safe and effective short-term.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Unprotected left main coronary artery (UPLM) stenosis is a critical condition requiring revascularization.
  • Percutaneous coronary intervention (PCI) with stents and coronary artery bypass graft surgery (CABG) are primary treatment options.
  • Comparative outcomes between PCI and CABG for UPLM stenosis require ongoing evaluation.

Purpose of the Study:

  • To conduct a meta-analysis comparing PCI with stents versus CABG for UPLM stenosis.
  • To evaluate key clinical outcomes including mortality, stroke, myocardial infarction, and revascularization rates.
  • To inform treatment decisions based on comparative efficacy and safety profiles.

Main Methods:

  • Systematic literature search of Cochrane Library, PubMed, and EMBASE databases up to July 2017.
  • Inclusion of randomized and prospective trials assessing PCI versus CABG for UPLM stenosis.
  • Quality assessment using the Newcastle-Ottawa scale; pooled analysis of 19 studies with 16,900 participants.

Main Results:

  • No significant differences in all-cause mortality (OR 0.94) or cardiac death (OR 1.04) between PCI and CABG.
  • PCI demonstrated significantly lower stroke rates in both short-term (OR 0.45) and long-term (OR 0.36) follow-up.
  • PCI was associated with higher risks of myocardial infarction (OR 1.59), repeat revascularization (OR 2.47), and target vessel revascularization (OR 2.10).

Conclusions:

  • PCI significantly reduces the risk of stroke compared to CABG, making it a preferred option for high-stroke-risk patients.
  • PCI is safe and effective in the short term for UPLM patients, with a notable reduction in 30-day mortality.
  • CABG is associated with fewer long-term complications, suggesting a potential benefit for durable outcomes.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
420
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
249
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
364
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
663
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
7.1K